Humira and Remicade

A May 2006 Mayo Clinic study published in the Journal of the American Medical Association has found that rheumatoid arthritis patients taking the anti-inflammatory drugs Humira and Remicade are three times more likely to develop cancers of the skin, lungs, breasts, and gastrointestinal system. Furthermore, researchers found that Humira and Remicade double the risk of serious infections such as eczema and other severe skin problems. While the overall risk of cancer and infection linked to Humira and Remicade remain small, researchers warn that the effects vary widely between patients.

If you or a loved one has suffered serious adverse side effects you believe were a result of Humira or Remicade, you may be eligible to seek compensation for your losses. It is wise to seek the help of a caring and competent personal injury attorney who can assess your case to determine the best course of action.

What are Humira and Remicade?

Abbot Laboratories' Humira and Centocor's Remicade are medications used to treat rheumatoid arthritis , an autoimmune condition affecting more than two million Americans, which causes painful, joint inflammation and deformity. Humira and Remicade belong to a class of TNF-blocking (tumor necrosis factor) drugs , which block the inflammatory process in the body reducing pain and increasing flexibility, range of motion, and life expectancy.

Remicade was approved by the U.S. Food and Drug Administration in 1998, and Humira was approved in 2002 for the treatment of rheumatoid arthritis as well as Crohn's disease, an inflammatory bowel condition. Currently, an estimated 500,000 people in the United States have been prescribed these medications.

Other Risks Linked to Humira and Remicade

The new Mayo Clinic study is not the first report linking Humira and Remicade to serious adverse side effects , but it is the only one to quantify the dangers as well as discover further types of cancer associated with the drugs. Previous studies have suggested an increased risk of infections such as tuberculosis and pneumonia linked to the use of Humira and Remicade. Past data also indicates the heightened risk of cancers such as lymphoma . In addition, a 2004 study warned doctors and patients of the increased risk of rare, but fatal liver damage in patients taking Humira and Remicade.

Who should not use Humira or Remicade?

Patients who have certain unusual allergies such as reactions to rodents should not use Humira or Remicade. In addition, patients with a history of medical conditions including heart disease, Hepatitis B, infections, or nervous system problems should speak to a doctor before using Humira or Remicade.

If you experience any symptoms of liver damage or lymphoma, or develop skin reactions, terminate the use of the medication and contact a doctor immediately.

Contact us today to learn more information about the risks of Humira and Remicade or to speak with a qualified and experienced personal injury FREE of charge.

Humira News:

May 17, 2006 - Remicade and Humira Cause Cancer, Infection